Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry. - Wikidata - awgldk - TriplyDB

Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry.

Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry.

http://www.wikidata.org/entity/Q37466558

about

Treatment of adult-onset still's disease: up to date.

P2860

Q38679486-1D6EAC70-48E6-482F-ADFA-A5C8A386A9BC

P2860

Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry.

http://www.wikidata.org/entity/Q37466558

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Comparative effectiveness of a ...... re in the US Corrona registry.

@en

Comparative effectiveness of a ...... re in the US Corrona registry.

@nl

type

label

Comparative effectiveness of a ...... re in the US Corrona registry.

@en

Comparative effectiveness of a ...... re in the US Corrona registry.

@nl

prefLabel

Comparative effectiveness of a ...... re in the US Corrona registry.

@en

Comparative effectiveness of a ...... re in the US Corrona registry.

@nl

P1433

Q37466558-A3858DD3-1E16-4462-843A-360E0636D7F5

P1476

Q37466558-232B739E-C3D9-4250-B7C1-F22C9F286E17

P2093

Q37466558-13A29402-A3C4-4A7A-9AD2-C222C37DB3F5

Q37466558-8C6A8FD9-DCFD-4A3B-AB9E-6470C963637A

Q37466558-C98D41F7-5088-4A3F-937D-19E8C014261B

Q37466558-CCDCDB70-8272-44EC-8DB5-6AD12469B923

Q37466558-E5B9C62E-CF58-4A98-B36D-72CC909A84BC

Q37466558-FBD35CE9-79EC-413C-8B23-8803B8004C90

Q37466558-FCD50C49-AF5E-4E75-BF4C-CF7576CC079B

P2860

Q37466558-036FA31D-D8C2-4F9D-8664-AA90A6C44259

Q37466558-0CB2EEBF-90EC-48B4-A7B1-544250FADE93

Q37466558-0E816DD3-75DE-4FC1-9028-78B63FD85E57

Q37466558-1042B84A-2F9D-4D86-8840-B4CD6D6CA384

Q37466558-160963BB-8585-4E3E-A233-4481294DC87C

Q37466558-1D2E0F50-73E4-4C65-B9B9-FCD43BAD46A7

Q37466558-33340490-AFEF-488B-97CB-2EC5D31A7061

Q37466558-36EDF073-1D9C-4DDB-B48E-6DEA99F21DC4

Q37466558-4A60CF4B-5224-4860-8691-F4B83AF7FC39

Q37466558-5C0CB737-F26B-4887-8B8F-48384DABB0B9

P2888

Q37466558-D2EA980F-F2B5-4874-9BA5-AF833B4B3668

P304

Q37466558-3C125189-86B4-40B2-BC6A-27A2C91E378C

P31

Q37466558-A3309605-0EEB-42E3-B538-293B624BEBC1

P356

Q37466558-C4D81958-AB62-468A-A722-74F8CC83DE19

P433

Q37466558-50F81067-EE89-4E51-897C-06FA13E1D901

P478

Q37466558-75F3788E-E002-4D8A-B6DC-D56ECD53741D

P577

Q37466558-00DD28CE-AE62-431D-A60D-37B124357157

P6179

Q37466558-75CF848C-E01E-490A-A771-3638FF7DC3C3

P698

Q37466558-44891D18-FB31-4A2E-953A-1A659F0ADA47

P932

Q37466558-88512559-0A9D-4E09-BE0B-D06A845555AE

P356

S13075-016-1179-7

P1433

Arthritis Research and Therapy

P1476

Comparative effectiveness of a ...... re in the US Corrona registry.

@en

P2093

Daniel H Solomon

http://www.w3.org/2001/XMLSchema#string

George W Reed

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Greenberg

http://www.w3.org/2001/XMLSchema#string

Jeffrey R Curtis

http://www.w3.org/2001/XMLSchema#string

Joel M Kremer

http://www.w3.org/2001/XMLSchema#string

Leslie R Harrold

http://www.w3.org/2001/XMLSchema#string

Mei Liu

http://www.w3.org/2001/XMLSchema#string

P2860

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research.

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?

Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice.

A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-cont

The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor.

P2888

s13075-016-1179-7

P304

280

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13075-016-1179-7

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1002549426

http://www.w3.org/2001/XMLSchema#string

P698

27906048

http://www.w3.org/2001/XMLSchema#string

P932

5134270

http://www.w3.org/2001/XMLSchema#string